About Arietis

About company

Arietis is a biotechnology company focused on the discovery and development of novel antimicrobial agents. The company develops first-in-class small molecule antibiotics to kill drug-resistant bacterial pathogens and treat infections with a high unmet clinical need. Its drug discovery pipeline focuses on sterilizing antibiotics that target Staphylococcus aureus, a leading cause of nosocomial and community-acquired infections, and Helicobacter pylori, a cause of gastric ulcers and cancer. A newer discovery platform involves using synthetic biology to manipulate the human gut microbiome to improve human health and cure disease. Arietis was founded in 2006 and is based in Boston, Massachusetts.